EUVIMEDEUVIMED entdecken
Crossref

Reactive Oxygen Species Triggered Cleavage of Thioketal‐Containing Supramolecular Nanoparticles for Inflammation‐Targeted Oral Therapy in Ulcerative Colitis

Ting Xiong, Huipeng Xu, Qin Nie, Bingqian Jia, Haojie Bao, Hanwen Zhang, Jing Li, Zeying Cao, Shunyao Wang, Li Wu, Jiwen Zhang

Advanced Functional Materials · 2025-01 · 35 (1)

DOI: 10.1002/adfm.202411979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 19.09.2024. Verfasst von Ting Xiong und 10 weiteren Autor:innen. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combating reactive oxygen species (ROS) and targeted drug delivery to inflammatory sites are considered effective therapeutic strategies for ulcerative colitis (UC), a refractory chronic inflammatory disease. Herein, a ROS‐responsive thioketal (TK) crosslinked cyclodextrin metal‐organic framework (TCOF) is fabricated, to which a non‐ROS‐sensitive vector, sulfur substituted by carbon chain‐crosslinked cyclodextrin metal‐organic framework (CCOF) is parallelly designed as ROS negative reference. Dexamethasone (DEX) loaded in TCOF (TCD) and CCOF (CCD) are investigated to demonstrate the advantages of precision medicine for UC. After the ROS‐induced collapse of nanoparticles, TCD selectively triggered the release of DEX. Moreover, TCD effectively protected cells from oxidative stress damage and reduced inflammation levels in vitro. Remarkably, the TK group of TCD is oxidatively broken by consuming ROS at the inflammatory site, exposing the thiol group to mucosal adhesion, which enhances the retention of TCD at colons. In vivo studies of UC treatment reveals that oral administration of TCD demonstrated excellent inflammation‐targeting properties, remarkably attenuated oxidative stress, and ameliorated both acute and chronic colitis compared to CCD. Furthermore, TCD exhibits an excellent safety profile in mice. These results instill confidence in advancing targeted drug delivery and precision therapy for UC.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xiong, T., Xu, H., Nie, Q., Jia, B., Bao, H., Zhang, H., Li, J., Cao, Z., Wang, S., Wu, L., & Zhang, J. (2025). Reactive Oxygen Species Triggered Cleavage of Thioketal‐Containing Supramolecular Nanoparticles for Inflammation‐Targeted Oral Therapy in Ulcerative Colitis. Advanced Functional Materials, 35(1). https://doi.org/10.1002/adfm.202411979

Vancouver

Xiong T, Xu H, Nie Q, Jia B, Bao H, Zhang H, et al. Reactive Oxygen Species Triggered Cleavage of Thioketal‐Containing Supramolecular Nanoparticles for Inflammation‐Targeted Oral Therapy in Ulcerative Colitis. Advanced Functional Materials. 2025;35(1). doi:10.1002/adfm.202411979

BibTeX
@article{Xiong2025,
  author = {Xiong, Ting and Xu, Huipeng and Nie, Qin and Jia, Bingqian and Bao, Haojie and Zhang, Hanwen and Li, Jing and Cao, Zeying and Wang, Shunyao and Wu, Li and Zhang, Jiwen},
  title = {Reactive Oxygen Species Triggered Cleavage of Thioketal‐Containing Supramolecular Nanoparticles for Inflammation‐Targeted Oral Therapy in Ulcerative Colitis},
  journal = {Advanced Functional Materials},
  year = {2025},
  volume = {35},
  number = {1},
  doi = {10.1002/adfm.202411979}
}
Kostenlos starten →